[Federal Register Volume 68, Number 233 (Thursday, December 4, 2003)]
[Notices]
[Pages 67850-67855]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-30146]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Sociocultural and Community Risk and Protective Factors for Child 
Maltreatment and Youth Violence

    Announcement Type: New.
    Funding Opportunity Number: 04056.
    Catalog of Federal Domestic Assistance Number: 93.136.
    Key Dates: Letter of Intent Deadline: January 5, 2004.
    Application Deadline: February 17, 2004.

I. Funding Opportunity Description

    Authority: This program is authorized under section 301(a) [42 
U.S.C. 241(a)] of the Public Health Service Act and section 391(a) 
[42 U.S.C. 280b(a)] of the Public Service Health Act, as amended.

    Purpose: The purpose of this program is to inform violence 
prevention efforts by testing the extent to which potentially 
modifiable sociocultural and community risk and protective factors are 
associated with child maltreatment and early risk factors for youth 
violence. This program addresses the ``Healthy People 2010'' focus area 
of Injury and Violence Prevention.
    Measurable outcomes of the program will be in alignment with the 
following performance goal for the National Center for Injury 
Prevention and Control (NCIPC): Conduct a targeted program of research 
to reduce injury-related death and disability.
    Research Objectives: Numerous researchers have stressed the 
importance of the influence of external environments on family 
functioning and risk for child maltreatment and subsequent youth 
violence, as well as the need for research based in an ecological-
developmental framework in which risk and protective factors transact 
across multiple individual and sociocultural contexts (See Attachment 
1, References 1-4 as published on the CDC Web site). However, to date, 
the majority of research on risk and protective factors for child 
maltreatment has focused on identifying individual characteristics of 
the child (e.g., temperament, cognitive and physical disability) and 
caregivers (e.g., alcohol/drug use, depression, history of childhood 
victimization) with fewer studies focusing on the larger community and 
sociocultural factors that influence these characteristics. In 
addition, although research has identified a number of early behavioral 
and family risk factors for youth

[[Page 67851]]

violence (e.g., early antisocial or aggressive behavior, poor parent-
child relations and parenting practices) few studies have examined how 
these factors are influenced by sociocultural and community factors 
(See Attachment 1 Reference 5 as published on the CDC Web site).
    The purpose of this program is to empirically demonstrate the 
predictive utility of potentially modifiable sociocultural and 
community characteristics to predict child maltreatment and early risk 
factors for youth violence. Previous research has described the 
importance of larger community and sociocultural factors such as access 
to social capital, community social organization, economic and family 
resources, residential instability, and community and family violence 
(See Attachment 1 References 6-8 under VIII. Other Information). 
However, limited information exists about the mechanisms through which 
these and other potentially modifiable risk and protective factors 
might have an impact on child maltreatment and the factors that place 
children on a developmental trajectory toward violence during later 
childhood, adolescence, and young adulthood. Modifiable factors include 
those that can be changed directly as well as those whose path to 
violence can be altered to reduce risk. By improving our understanding 
of how potentially modifiable community and sociocultural factors are 
associated with child maltreatment and early risk factors for youth 
violence the results from this research will inform the development of 
violence prevention strategies.
    Protocols may include data from a variety of sources such as 
existing or new self-report data, observational data, or archival data. 
The proposed design and analysis plan should include an assessment of 
multiple levels of influence (e.g., peer, family, neighborhood, school, 
and/or community; cf., Coulton et al., 1999; Sampson et al., 2002) with 
emphasis on the effects of the broader community and sociocultural 
contexts on these levels of influence.
    Protocols should be designed to assess (1) the potentially 
modifiable sociocultural and community factors that are hypothesized to 
influence risk for child maltreatment and early risk factors for youth 
violence; (2) multiple indicators of child maltreatment (e.g., neglect, 
physical, and/or sexual abuse) and early risk factors for youth 
violence (e.g., early antisocial or aggressive behavior, poor parent-
child relations); and (3) potential mechanisms through which larger 
community and sociocultural factors may influence risk at the 
individual and family levels.
    In addition to the measurable outcomes with respect to performance 
goal, measurable outcomes of the program will be in alignment with the 
following research agenda items for the National Center for Injury 
Prevention and Control (NCIPC):
    A. Identify modifiable sociocultural and community factors that 
influence youth violence.
    B. Examine the development of child maltreatment perpetration (at 
the community level) to identify at-risk populations, modifiable risk 
and protective factors, and optimal times and settings for 
intervention. (See Attachment 1 Reference 9 as published on the CDC Web 
site.)
    Activities: Awardee activities for this program are as follows:
    a. Develop and finalize the research design and methodology, data 
collection measures and analyses, and disseminate the study results 
through publications and presentations.
    b. Develop a research protocol for Institutional Review Board (IRB) 
review by all cooperating institutions participating in the research 
project.
    c. Obtain approval of the study protocol by the recipient's local 
IRB.
    d. Form and maintain a community advisory committee to provide 
guidance on the development of research protocol and the interpretation 
and dissemination of the study results. Members should include 
representatives and practitioners from agencies and organizations that 
engage in related research or service provision, and representatives of 
the communities targeted in the research.
    e. Finalize and implement a research protocol focusing on 
identifying modifiable sociocultural and community-level 
characteristics that are hypothesized to predict child maltreatment and 
early risk factors for youth violence.
    f. Finalize, pilot test, revise, and implement data collection 
instruments.
    g. Analyze data and interpret findings focusing on sociocultural 
and community characteristics that predict child maltreatment and early 
risk factors for youth violence.
    h. Conduct one reverse site visit to meet with CDC staff in Atlanta 
on an annual basis.
    i. Complete all required reports as specified under ``Reporting 
Requirements''.

In a cooperative agreement, CDC staff is substantially involved in the 
program activities, above and beyond routine grant monitoring.
    CDC Activities for this program are as follows:
    a. Provide scientific and programmatic consultation. CDC will 
collaborate with project staff on research design and methodology, and 
analysis and dissemination of the study results in publications and 
presentations.
    b. Assist in the development of a research protocol for IRB review 
by all cooperating institutions participating in the research project. 
The CDC IRB will review and approve the protocol initially and on at 
least an annual basis until the research project is finished.
    c. Provide technical assistance on the selection and evaluation of 
the data collection instruments.
    d. Facilitate an annual meeting between awardee and CDC to 
coordinate planned efforts and review progress.

II. Award Information

    Type of Award: Cooperative Agreement. CDC involvement in this 
program is listed in the Activities Section above.
    Fiscal Year Funds: 2004.
    Approximate Total Funding: $500,000.
    Approximate Number of Awards: One.
    Approximate Average Award: $500,000.
    Floor of Award Range: None.
    Ceiling of Award Range: $500,000.
    Anticipated Award Date: August 2, 2004.
    Budget Period Length: 12 months.
    Project Period Length: Four years.
    Throughout the project period, CDC's commitment to continuation of 
awards will be conditioned on the availability of funds, evidence of 
satisfactory progress by the recipient (as documented in required 
reports), and the determination that continued funding is in the best 
interest of the Federal Government.

III. Eligibility Information

    1. Eligible applicants: Applications may be submitted by public and 
nonprofit private and for profit organizations and by governments and 
their agencies, such as:
    [sbull] Public nonprofit organizations.
    [sbull] Private nonprofit organizations.
    [sbull] For profit organizations.
    [sbull] Small, minority, women-owned businesses.
    [sbull] Universities.
    [sbull] Colleges.
    [sbull] Research institutions.
    [sbull] Hospitals.
    [sbull] Community-based organizations.
    [sbull] Faith-based organizations.
    [sbull] Federally recognized Indian tribal governments.

[[Page 67852]]

    [sbull] Indian tribes.
    [sbull] Indian tribal organizations.
    [sbull] State and local governments or their Bona Fide Agents (this 
includes the District of Columbia, the Commonwealth of Puerto Rico, the 
Virgin Islands, the Commonwealth of the Northern Marianna Islands, 
American Samoa, Guam, the Federated States of Micronesia, the Republic 
of the Marshall Islands, and the Republic of Palau).
    [sbull] Political subdivisions of States (in consultation with 
States).

A Bona Fide Agent is an agency/organization identified by the state as 
eligible to submit an application under the state eligibility in lieu 
of a state application. If you are applying as a bona fide agent of a 
state or local government, you must provide a letter from the state or 
local government as documentation of your status. Place this 
documentation behind the first page of your application form.
    Foreign institutions are not eligible to apply.
    2. Cost Sharing or Matching: Matching funds are not required for 
this program.
    3. Other Eligibility Requirements: If your application is 
incomplete or non-responsive to the requirements listed below, it will 
not be entered into the review process. You will be notified that your 
application did not meet submission requirements. The following 
applicant requirements are:
    [sbull] A principal investigator who has conducted research, 
published the findings in peer-reviewed journals, and has specific 
authority and responsibility given by their research institution to 
carry out the proposed project.
    [sbull] Demonstrated experience on the applicant's project team in 
conducting, evaluating, and publishing violence prevention research in 
peer-reviewed journals.
    [sbull] Effective and well-defined working relationships within the 
performing organization and with outside entities, which will ensure 
implementation of the proposed activities.
    [sbull] The overall match between the applicant's proposed research 
objectives and the program priorities as described under the heading, 
``Research Objectives''.
    [sbull] The requested funding amount should not be greater than the 
ceiling of the award range.
    [sbull] Principal investigators (PI's) are encouraged to submit 
only one proposal in response to this program announcement. With few 
exceptions (e.g., research issues needing immediate public health 
attention), only one application per PI will be funded under this 
announcement.

    Note: Title 2 of the United States Code section 1611 states that 
an organization described in section 501(c)(4) of the Internal 
Revenue Code that engages in lobbying activities is not eligible to 
receive Federal funds constituting an award, grant, or loan.

IV. Application and Submission Information

    1. Address to Request Application Package: To apply for this 
funding opportunity, use application form PHS 398 (OMB number 0925-0001 
rev. 5/2001). Forms and instructions are available in an interactive 
format on the CDC web site, at the following Internet address: 
www.cdc.gov/od/pgo/forminfo.htm.
    Forms and instructions are also available in an interactive format 
on the National Institutes of Health (NIH) web site at the following 
Internet address: http://grants.nih.gov/grants/funding/phs398/phs398.html.
    If you do not have access to the Internet, or if you have 
difficulty accessing the forms on-line, you may contact the CDC 
Procurement and Grants Office Technical Information Management Section 
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to 
you. For further assistance with the PHS 398 application form, contact 
GrantsInfo, telephone (301) 435-0714, E-mail: [email protected].
    2. Content and Form of Application Submission: Letter of Intent 
(LOI): CDC requests that you send a LOI if you intend to apply for this 
program. Although the LOI is not required, not binding, and does not 
enter into the review of your subsequent application, your LOI will be 
used to gauge the level of interest in this program, and to allow CDC 
to plan the application review. Your LOI must be written in the 
following format:
    [sbull] Maximum number of pages: Two
    [sbull] Single spaced
    [sbull] Font size: 12-point unreduced
    [sbull] Paper size: 8.5 by 11 inches
    [sbull] Page margin size: One inch
    [sbull] Printed only on one side of page
    [sbull] Written in English, avoid jargon
    Your LOI must contain the following information:
    [sbull] Descriptive title of the proposed research.
    [sbull] Name, address, E-mail address, and telephone number of the 
Principal Investigator.
    [sbull] Names of other key personnel.
    [sbull] Participating institutions.
    [sbull] Number and title of this Program Announcement (PA).
    Application: Follow the PHS 398 application instructions for 
content and formatting of your application. For further assistance with 
the PHS 398 application form, contact GrantsInfo, Telephone (301) 435-
0714, E-mail: [email protected].
    See Attachment 2 of this announcement as it is posted on the CDC 
web site for guidance on how to complete Form 398 for this Program 
Announcement. The Program Announcement Title and number must appear in 
the application.
    You must include a research plan with your application. The 
research plan should be no more than 25 pages (8.5[sec] x 11[sec] in 
size), single-spaced, printed on one side only, with one-inch margins 
on all sides, and unreduced 12-point font.
    Your application will be evaluated on the criteria listed under 
Section V. Application Review Information, so it is important to follow 
them, as well as the Research Objectives and the Administrative and 
National Policy Requirements (AR's), in laying out your research plan. 
Your research plan should address activities to be conducted over the 
entire project period.
    The research plan should consist of the following information:
    1. Research Plan. Provide a brief one-page description of proposed 
activities and project outcomes.
    2. Goals and Objectives. Describe the goals and objectives the 
proposed research is designed to achieve in the short and long term. 
Specific research questions and hypotheses should also be included. In 
addition, the proposal should include an outline of a four-year plan 
with timeline.
    3. Program Participants. Describe the study population for the 
proposed research and how participants will be selected (i.e., sampling 
strategy). In addition, the research plan should provide evidence that 
the recipient (or a collaborating partner) has access to the study 
population, and that the participation by the study population will be 
adequate to test hypotheses.
    4. Methods. Describe the proposed study design; methodology, and 
analysis plan to test the proposed hypotheses.
    5. Project Management. Provide evidence of the expertise, capacity, 
and existing staff necessary to successfully conduct the research. Each 
existing or proposed position for the project should be described by 
job title, function, general duties, level of effort and allocation of 
time. Management operation principles, structure, and organization 
should also be noted.
    6. Collaboration. Describe plans to convene a community advisory 
committee that will guide the development of research protocols and

[[Page 67853]]

inform the interpretation and dissemination of the study results. 
Members should include representatives and practitioners from agencies 
and organizations that engage in related research or service provision, 
and representatives of the communities targeted in the proposed 
research. Include letters of support from collaborating partners in the 
project that document specific contributions, past collaborations, 
products, services, and other activities that will be provided by and 
to the applicant through the proposed collaboration.
    7. Project Budget. Provide a detailed budget for each activity 
undertaken, with accompanying justification of all operating expenses 
that is consistent with the stated objectives and planned activities of 
the project. The budget should include at least one trip per year to 
CDC for program related meetings. This program announcement does not 
use the modular budget format.
    You are required to have a Dun and Bradstreet Data Universal 
Numbering System (DUNS) number to apply for a grant or cooperative 
agreement from the Federal government. Your DUNS number must be entered 
in item 11 of the face page of the PHS 398 application form. The DUNS 
number is a nine-digit identification number, which uniquely identifies 
business entities. Obtaining a DUNS number is easy and there is no 
charge. To obtain a DUNS number, access www.dunandbradstreet.com or 
call 1-866-705-5711. For more information, see the CDC Web site at: 
http://www.cdc.gov/od/pgo/funding/pubcommt.htm
    3. Submission Dates and Times: LOI Deadline Date: January 5, 2004. 
Application Deadline Date: February 17, 2004.
    Explanation of Deadlines: Applications must be received in the CDC 
Procurement and Grants Office by 4 p.m. Eastern Time on the deadline 
date. If you send your application by the United States Postal Service 
or commercial delivery service, you must ensure that the carrier will 
be able to guarantee delivery of the application by the closing date 
and time. If CDC receives your application after closing due to: (1) 
Carrier error, when the carrier accepted the package with a guarantee 
for delivery by the closing date and time, or (2) significant weather 
delays or natural disasters, you will be given the opportunity to 
submit documentation of the carriers guarantee. If the documentation 
verifies a carrier problem, CDC will consider the application as having 
been received by the deadline.
    This announcement is the definitive guide on application submission 
address and deadline. It supersedes information provided in the 
application instructions. If your application does not meet the 
deadline above, it will not be eligible for review, and will be 
discarded. You will be notified that you did not meet the submission 
requirements.
    CDC will not notify you upon receipt of your application. If you 
have a question about the receipt of your application, first contact 
your courier. If you still have a question, contact the PGO-TIM staff 
at: 770-488-2700. Before calling, please wait two to three days after 
the application deadline. This will allow time for applications to be 
processed and logged.
    4. Intergovernmental Review of Applications: Executive Order 12372 
does not apply to this program.
    5. Funding Restrictions: Restrictions, which must be taken into 
account while writing your budget, are as follows: None.
    If you are requesting indirect costs in your budget, you must 
include a copy of your indirect cost rate agreement. If your indirect 
cost rate is a provisional rate, the agreement must be less than 12 
months of age.
    6. Other Submission Requirements: LOI Submission Address: Submit 
your LOI by express mail, delivery service, fax, or e-mail to: Robin 
Forbes, CDC, NCIPC, 4770 Buford Hwy, Mailstop K-62, Atlanta, GA 30341, 
Phone: 770-488-4037, E-mail: [email protected].
    Application Submission Address: Submit the original and five copies 
of your application by mail or express delivery service to: Technical 
Information Management-PA 04056, CDC Procurement and Grants 
Office, 2920 Brandywine Road, Atlanta, GA 30341.
    Applications may not be submitted electronically at this time.

V. Application Review Information

    1. Criteria: You are required to provide measures of effectiveness 
that will demonstrate the accomplishment of the various identified 
objectives of the cooperative agreement. Measures of effectiveness must 
relate to the performance goals stated in the ``Purpose'' section of 
this announcement. Measures must be objective and quantitative, and 
must measure the intended outcome. These measures of effectiveness must 
be submitted with the application and will be an element of evaluation.
    The goals of CDC-supported research are to advance the 
understanding of biological systems, improve the control and prevention 
of disease, and enhance health. In the written comments, reviewers will 
be asked to evaluate the application in order to judge the likelihood 
that the proposed research will have a substantial impact on the 
pursuit of these goals. The scientific review group will address and 
consider each of the following criteria in assigning the application's 
overall score, weighting them as appropriate for each application.
    The application does not need to be strong in all categories to be 
judged likely to have major scientific impact and thus deserve a high 
priority score. For example, an investigator may propose to carry out 
important work that by its nature is not innovative, but is essential 
to move a field forward.
    The criteria are as follows:
    Significance: Does this study address an important problem? If the 
aims of the application are achieved, how will scientific knowledge be 
advanced? What will be the effect of these studies on the concepts or 
methods that drive this field?
    Approach: Are the conceptual framework, design, methods, and 
analyses adequately developed, scientifically rigorous, well 
integrated, and appropriate to the aims of the project? Does the 
applicant acknowledge potential problem areas and consider alternative 
tactics?
    Innovation: Does the project employ novel concepts, approaches or 
methods? Are the aims original and innovative? Does the project 
challenge existing paradigms or develop new methodologies or 
technologies?
    Investigator: Is the investigator appropriately trained and well 
suited to carry out this work? Is the work proposed appropriate to the 
experience level of the principal investigator and other researchers 
(if any)?
    Environment: Does the scientific environment in which the work will 
be done contribute to the probability of success? Does the proposed 
research take advantage of unique features of the scientific 
environment or employ useful collaborative arrangements? Is there 
evidence of institutional support?
    Additional Review Criteria: In addition to the above criteria, the 
following items will be considered.
    Protection of Human Subjects from Research Risks: Does the 
application adequately address the requirements of Title 45 CFR Part 46 
for the protection of human subjects? This will not be scored; however, 
an application can be disapproved if the research risks are 
sufficiently serious and protection against risks is so inadequate as 
to make the entire application unacceptable.

[[Page 67854]]

    Inclusion of Women and Minorities in Research: Does the application 
adequately address the CDC Policy requirements regarding the inclusion 
of women, ethnic, and racial groups in the proposed research? This 
includes: (1) The proposed plan for the inclusion of both sexes and 
racial and ethnic minority populations for appropriate representation; 
(2) The proposed justification when representation is limited or 
absent; (3) A statement as to whether the design of the study is 
adequate to measure differences when warranted; and (4) A statement as 
to whether the plans for recruitment and outreach for study 
participants include the process of establishing partnerships with 
community(ies) and recognition of mutual benefits.
    Inclusion of Children as Participants in Research Involving Human 
Subjects: The NIH maintains a policy that children (i.e., individuals 
under the age of 21) must be included in all human subjects research, 
conducted or supported by the NIH, unless there are scientific and 
ethical reasons not to include them. This policy applies to all initial 
(Type 1) applications submitted for receipt dates after October 1, 
1998.
    All investigators proposing research involving human subjects 
should read the ``NIH Policy and Guidelines'' on the inclusion of 
children as participants in research involving human subjects that is 
available at: http://grants.nih.gov/grants/funding/children/children.htm.
    Budget: The reasonableness of the proposed budget and the requested 
period of support in relation to the proposed research.
    2. Review and Selection Process: Applications will be reviewed for 
completeness by the Procurement and Grants Office (PGO) and for 
responsiveness of other eligibility requirements by NCIPC. Incomplete 
applications and applications that are non-responsive will not advance 
through the review process. You will be notified that you did not meet 
submission requirements.
    Applications that are complete and responsive to the announcement 
will be subjected to a preliminary evaluation (streamline review) by a 
peer review committee, the Initial Review Group (IRG), convened by 
NCIPC, to determine if the application is of sufficient technical and 
scientific merit to warrant further review by the IRG. CDC will 
withdraw from further consideration applications judged to be 
noncompetitive and promptly notify the principal investigator or 
program director and the official signing for the applicant 
organization. Those applications judged to be competitive will be 
further evaluated by a dual review process.
    1. The primary review will be a peer review conducted by the IRG. 
All applications will be reviewed for scientific merit in accordance 
with the review criteria listed above. Applications will be assigned a 
priority score based on the National Institutes of Health (NIH) scoring 
system of 100-500 points.
    2. The secondary review will be conducted by the Science and 
Program Review Subcommittee (SPRS) of NCIPC's Advisory Committee for 
Injury Prevention and Control (ACIPC). The ACIPC Federal agency experts 
will be invited to attend the secondary review, and will receive 
modified briefing books (i.e., abstracts, strengths and weaknesses from 
summary statements, and project officer's briefing materials). ACIPC 
Federal agency experts will be encouraged to participate in 
deliberations when applications address overlapping areas of research 
interest, so that unwarranted duplication in federally funded research 
can be avoided and special subject area expertise can be shared. The 
NCIPC Division Associate Directors for Science (ADS) or their designees 
will attend the secondary review in a similar capacity as the ACIPC 
Federal agency experts to assure that research priorities of the 
announcement are understood and to provide background regarding current 
research activities. Only SPRS members will vote on funding 
recommendations, and their recommendations will be carried to the 
entire ACIPC for voting by the ACIPC members in closed session. If any 
further review is needed by the ACIPC, regarding the recommendations of 
the SPRS, the factors considered will be the same as those considered 
by the SPRS.
    The committee's responsibility is to develop funding 
recommendations for the NCIPC Director based on the results of the 
primary review, the relevance and balance of proposed research relative 
to the NCIPC programs and priorities, and to assure that unwarranted 
duplication of federally funded research does not occur. The secondary 
review committee has the latitude to recommend to the NCIPC Director, 
to reach over better-ranked proposals in order to assure maximal impact 
and balance of proposed research. The factors to be considered will 
include:
    a. The results of the primary review including the application's 
priority score as the primary factor in the selection process.
    b. The relevance and balance of proposed research relative to the 
NCIPC programs and priorities.
    c. The significance of the proposed activities in relation to the 
priorities and objectives stated in Healthy People 2010, Reducing the 
Burden of Injury (Bonnie, RJ, Fulco, CE, and CT Liverman. Reducing the 
Burden of Injury. Institute of Medicine. National Academy Press: 1999) 
and the CDC Injury Research Agenda (National Center for Injury 
Prevention and Control. CDC Injury Research Agenda. Atlanta (GA): 
Centers for Disease Control and Prevention; 2002).
    All awards will be determined by the Director of the NCIPC based on 
priority scores assigned to applications by the IRG, recommendations by 
the secondary review committee, e.g., NCIPC's Advisory Committee for 
Injury Prevention and Control (ACIPC), consultation with NCIPC senior 
staff, and the availability of funds.

VI. Award Administration Information

    1. Award Notices: Successful applicants will receive a Notice of 
Grant Award (NGA) from the CDC Procurement and Grants Office. The NGA 
shall be the only binding, authorizing document between the recipient 
and CDC. The NGA will be signed by an authorized Grants Management 
Officer, and mailed to the recipient fiscal officer identified in the 
application.
    2. Administrative and National Policy Requirements: 45 CFR Part 74 
and 92.
    For more information on the Code of Federal Regulations, see the 
National Archives and Records Administration at the following Internet 
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html
    The following additional requirements apply to this project:
    [sbull] AR-1 Human Subjects Requirements.
    [sbull] AR-2 Requirements for Inclusion of Women and Racial and 
Ethnic Minorities in Research.
    [sbull] AR-7 Executive Order 12372.
    [sbull] AR-8 Public Health System Reporting Requirements.
    [sbull] AR-9 Paperwork Reduction Act Requirements.
    [sbull] AR-10 Smoke-Free Workplace Requirements.
    [sbull] AR-11 Healthy People 2010.
    [sbull] AR-12 Lobbying Restrictions.
    [sbull] AR-13 Prohibition on Use of CDC Funds for Certain Gun 
Control Activities.
    [sbull] AR-14 Accounting System Requirements.
    [sbull] AR-15 Proof of Non-Profit Status.
    [sbull] AR-21 Small, Minority, and Women-Owned Business.
    [sbull] AR-22 Research Integrity.
    [sbull] AR-23 States and Faith-Based Organizations.

[[Page 67855]]

    [sbull] AR-24 Health Insurance Portability and Accountability Act 
Requirements.
    [sbull] AR-25 Release and Sharing of Data.
    Starting with the December 1, 2003 receipt date, all NCIPC funded 
investigators seeking more than $500,000 in total costs in a single 
year are expected to include a plan describing how the final research 
data will be shared/released or explain why data sharing is not 
possible. Details on data sharing/release, including the timeliness and 
name of the project data steward, should be included in a brief 
paragraph immediately following the Research Plan Section of the PHS 
398 form. References to data sharing/release may also be appropriate in 
other sections of the application (e.g. background and significance, 
human subjects requirements, etc.) The content of the data sharing/
release plan will vary, depending on the data being collected and how 
the investigator is planning to share the data. The data sharing/
release plan will not count towards the application page limit and will 
not factor into the determination scientific merit or priority scores. 
Investigators should seek guidance from their institutions, on issues 
related to institutional policies, local IRB rules, as well as local, 
state and Federal laws and regulations, including the Privacy Rule.
    Further detail on the requirements for addressing data sharing in 
applications for NCIPC funding may be obtained by contacting NCIPC 
program staff or visiting the NCIPC internet Web site: at http://www.cdc.gov/ncipc/osp/sharing_policy.htm. Additional information on 
these requirements can be found on the CDC Web site at the following 
Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm.
    3. Reporting: You must provide CDC with an original, plus two 
copies of the following reports:
    1.Interim progress report, (PHS 2590, OMB Number 0925-0001, rev. 5/
2001) no less than 90 days before the end of the budget period. The 
progress report will serve as your non-competing continuation 
application, and must contain the following elements:
    a. Current Budget Period Activities Objectives.
    b. Current Budget Period Financial Progress.
    c. New Budget Period Program Proposed Activity Objectives.
    d. Detailed Line-Item Budget and Justification.
    e. Additional Requested Information.
    2.Financial status report, no more than 90 days after the end of 
the budget period.
    3.Final financial and performance reports, no more than 90 days 
after the end of the project period.

VII. Agency Contacts

    For general questions about this announcement, contact: Technical 
Information Management Section, CDC Procurement and Grants Office, 2920 
Brandywine Road, Atlanta, GA 30341, Telephone: 770-488-2700.
    For scientific/research program technical assistance, contact: 
Cindi Melanson, Project Officer, National Center for Injury Prevention 
and Control, 4470 Buford Highway, NE MS K-60, Atlanta, GA 30342, 
Telephone: 770-488-1530, E-mail: [email protected].
    For questions about peer review, contact: Gwen Cattledge, 
Scientific Review Administrator, Centers for Disease Control and 
Prevention, National Center for Injury Prevention and Control, 4470 
Buford Highway, NE Mailstop K-02, Atlanta, GA 30342, Telephone: 770-
488-1430, E-mail: [email protected].
    For budget assistance, contact: Nancy Pillar, Grants Management (or 
Contract) Specialist, CDC Procurement and Grants Office, 2920 
Brandywine Road, Atlanta, GA 30341, Telephone: 770-488-2721, E-mail: 
[email protected].

    Dated: November 28, 2003.
Edward Schultz,
Acting Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention.
[FR Doc. 03-30146 Filed 12-3-03; 8:45 am]
BILLING CODE 4163-18-U